WO2019026336A1

WO2019026336A1 - Efficacious ingredient holding sheet production method, efficacious ingredient holding sheet production device, efficacious ingredient holding sheet, and base material

Info

Publication number: WO2019026336A1
Application number: PCT/JP2018/012154
Authority: WO
Inventors: 敏秀前坂
Original assignee: 理想科学工業株式会社
Priority date: 2017-07-31
Filing date: 2018-03-26
Publication date: 2019-02-07
Also published as: JP7002240B2; CN110913825B; JP2019026599A; KR102400878B1; KR20200018693A; CN110913825A

Abstract

In this invention, a sheet-shaped base material is impregnated with a solution of an efficacious ingredient, corresponding to biological information, which is applied with an efficacious ingredient solution applicator (17).

Description

Method of producing effect component holding sheet, production device of effect component holding sheet, effect component holding sheet, and base material

The present invention relates to a method for producing an efficacy ingredient holding sheet, an apparatus for producing an efficacy ingredient holding sheet, an efficacy ingredient holding sheet, and a substrate.

There is known an efficacy component holding sheet which holds an efficacy component for a living body and is stuck to a living body to exhibit its efficacy.

For example, Patent Document 1 discloses a face pack as such an effect component holding sheet. This face pack is a cloth impregnated with a pack agent containing an efficacy component. By sticking the face pack on the face of the user, the pack agent exerts its effect on the skin of the face.

JP 2003-226633 A

However, in the face pack as described in Patent Document 1, since the efficacy component determined in advance is impregnated, an appropriate efficacy may not be exhibited in accordance with the condition of the skin of the user. Therefore, there has been a demand for enhancing the efficacy to the living body in an efficacy component holding sheet such as a face pack.

The present invention has been made in view of the above, and it is an object of the present invention to provide a method for producing an efficacy ingredient holding sheet capable of enhancing the efficacy for a living body, an apparatus for producing an efficacy ingredient holding sheet, an efficacy ingredient holding sheet, and a substrate. I assume.

In order to achieve the above object, according to a first aspect of the present invention, there is provided a method of producing an efficacy component holding sheet to be attached to a living body, wherein an efficacy component liquid according to biological information is used for a sheet-like substrate. A method of producing an efficacy ingredient holding sheet is provided, comprising the step of impregnating.

According to a second aspect of the present invention, there is provided a method of producing an efficacy component holding sheet to be attached to a living body, comprising the step of impregnating different types of efficacy component liquids in different regions with respect to a sheet-like substrate. There is provided a method of producing an efficacy ingredient holding sheet characterized by comprising.

According to a third aspect of the present invention, an apparatus for producing an efficacy component holding sheet to be attached to a living body, which is an efficacy component liquid to be applied and impregnated according to biological information to a sheet-like base material There is provided an apparatus for producing an efficacy ingredient holding sheet, which comprises an ingredient liquid application unit.

According to a fourth aspect of the present invention, there is provided an apparatus for producing an efficacy component holding sheet to be attached to a living body, comprising applying plural types of efficacy component liquids to different regions of a sheet-like substrate to impregnate them. There is provided an apparatus for producing an efficacy ingredient holding sheet comprising:

According to a fifth aspect of the present invention, there is provided an efficacy component holding sheet to be attached to a living body, comprising a sheet-like base material, wherein the base material is impregnated with an efficacy component liquid according to biological information. An efficacy ingredient holding sheet is provided.

According to a sixth aspect of the present invention, there is provided an efficacy component holding sheet to be attached to a living body, comprising: a sheet-like base material; and a plurality of the base materials impregnated with efficacy component liquids of different types. An effect ingredient holding sheet is provided, characterized in that
According to the seventh aspect of the present invention, it is a base material, which is formed according to the three-dimensional shape of the living body surface to which the efficacy component holding sheet is to be attached, and which cuts the base material along the living body surface There is provided a substrate characterized by comprising:

According to the first to seventh aspects of the present invention, the efficacy of the efficacy component holding sheet on the living body can be enhanced.

FIG. 1 is a schematic configuration diagram of a face pack manufacturing apparatus according to an embodiment. FIG. 2 is a schematic block diagram of a print engine unit of the face pack manufacturing apparatus shown in FIG. FIG. 3 is a control block diagram of the face pack manufacturing apparatus shown in FIG. FIG. 4 is an explanatory diagram of face information. FIG. 5 is a flowchart of a method of manufacturing a face pack. FIG. 6 is an explanatory view of discharge data. FIG. 7 is an explanatory view of a support forming step. FIG. 8 is an explanatory view of an efficacy component liquid discharge process. FIG. 9 is a plan view of the face pack. FIG. 10 is a partial cross-sectional view of the face pack. FIG. 11 is a partial cross-sectional view of the face pack in a region in which a carrier is impregnated with a plurality of types of efficacy component liquids. FIG. 12 is an explanatory view of the concavo-convex shape of the surface of the holder. FIG. 13 is an explanatory view of a support reduction portion. FIG. 14 is an explanatory view of a support-omitted part. FIG. 15 is an explanatory view of a holder omission part.

Hereinafter, embodiments of the present invention will be described with reference to the drawings. The same or equivalent parts or components are denoted by the same or equivalent reference numerals throughout the drawings.

The embodiment shown below exemplifies an apparatus etc. for embodying the technical idea of this invention, and the technical idea of this invention is the material, shape, structure, arrangement etc. of each component. Does not specify the following. Various changes can be added to the technical idea of the present invention within the scope of the claims.

FIG. 1 is a schematic configuration view of a face pack manufacturing apparatus (an apparatus for manufacturing an efficacy component holding sheet) according to an embodiment of the present invention. FIG. 2 is a schematic block diagram of a print engine unit of the face pack manufacturing apparatus shown in FIG. FIG. 3 is a control block diagram of the face pack manufacturing apparatus shown in FIG. In the following description, the direction perpendicular to the paper surface of FIG. 1 is referred to as the front-rear direction, and the front direction of the paper surface is referred to as the front. Further, the top, bottom, left, and right of the paper surface in FIG. 1 are the top, bottom, left, and right directions.

As shown in FIGS. 1 and 3, the face pack manufacturing apparatus 1 according to the present embodiment includes a measuring unit 2, a print engine unit 3, a print engine moving mechanism unit 4, a supply unit 5, and a conveyance unit 6. , A receiving unit 7, and a control unit 8. Here, the face pack manufacturing apparatus 1 is an apparatus for manufacturing a face pack (effect ingredient holding sheet) which is attached to the face (living body surface) of a person (living body) to exhibit its effects.

The measurement unit 2 measures the user's face. This measurement is for acquiring user's face information (biometric information).

Here, as shown in FIG. 4, the face information includes face shape information (three-dimensional shape information), a melamine value, a hemoglobin value, and a skin moisture amount.

Face shape information is information indicating the three-dimensional shape of the user's face. The three-dimensional shape of the face includes the contour of the face and the three-dimensional shape of the outer shape of the entire face formed by the shape, arrangement, and the like of each part such as eyes, nose, mouth and cheeks, and irregularities on the skin surface of the face due to wrinkles. The shape is included. The face shape information is acquired as three-dimensional imaging data by performing three-dimensional imaging of the face by the three-dimensional imaging unit 11 described later.

Melanin level is information indicating the degree of symptoms of freckles, stains and hidden stains. The melanin value which shows a freckle and a stain is acquired by carrying out color imaging of the face with the three-dimensional imaging part 11 mentioned later, and analyzing three-dimensional imaging data. In addition, a melanin value indicating a hidden stain is acquired by performing UV (ultraviolet light) imaging of a face by a three-dimensional imaging unit 11 described later and analyzing three-dimensional imaging data.

The hemoglobin value is information indicating the degree of skin redness and acne symptoms. The hemoglobin value is acquired by performing color imaging of the face by the three-dimensional imaging unit 11 described later and analyzing three-dimensional imaging data.

The skin water content is information indicating the degree of symptoms of skin soak. The skin water content is obtained by contact measurement on the skin by the skin water content measurement unit 12 described later.

The measurement part 2 is provided with the three-dimensional imaging part 11 and the skin water content measurement part 12 as shown in FIG.

The three-dimensional imaging unit 11 three-dimensionally captures the face of the user to generate three-dimensional imaging data. The three-dimensional imaging unit 11 is configured of a three-dimensional imaging device capable of three-dimensional color imaging and UV imaging.

The skin water content measurement unit 12 measures the skin water content by contact measurement on the skin. The skin water content measurement unit 12 is configured of, for example, Corneometer (registered trademark).

The print engine unit 3 forms a face pack 61 described later by an inkjet printing method. As shown in FIGS. 2 and 3, the print engine unit 3 includes a base material forming unit 16 and an effect component liquid applying unit 17.

The base forming portion 16 forms the base 62 of the face pack 61. The base material forming unit 16 includes a base material head 21,

UV irradiation units

22A and 22B, and drying

units

23A and 23B. The suffixes of the alphabets in the reference numerals of the

UV irradiation units

22A and 22B, the drying

units

23A and 23B, and the like may be omitted and collectively described.

The substrate head 21 is a droplet discharge head that discharges a support formation liquid and a support formation liquid. As the substrate head 21, an inkjet head that discharges ink in an inkjet printing apparatus is used. The substrate head 21 is formed of a multi-drop type ink jet head capable of discharging a plurality of droplets to one pixel. The substrate head 21 has two nozzle rows (not shown). The base material head 21 discharges the support formation liquid from the nozzles of one nozzle row, and discharges the support formation liquid from the nozzles of the other nozzle row.

Here, the support formation liquid is a liquid which is a material for forming a support 63 of a base 62 described later. Specifically, the support formation liquid is a liquid of a UV curable resin for forming a support 63 made of a liquid impermeable film. The carrier forming solution is a liquid which is a material for forming the carrier 64 of the base 62. Specifically, the carrier forming liquid is a liquid pulp.

Each of the

UV irradiation units

22A and 22B irradiates the support forming solution, which is a liquid of a UV curable resin discharged from the base material head 21 to a belt 46 of the transport unit 6 described later, with ultraviolet rays, Cure. The support forming liquid is not limited to the liquid of the UV curable resin, and may be a liquid such as an energy curable resin including a solvent ink, an aqueous ink, a hot melt ink, etc. in addition to the UV curable resin. . Further, the method of curing the support forming solution is not limited to the method of irradiating ultraviolet light (UV), and in addition to ultraviolet light, the active energy ray including infrared light (IR), electron beam (EB), etc. is irradiated. Any method is acceptable. Furthermore, the method of forming the support 63 of the substrate 62 is not limited to the method of solidifying the support forming solution, and a method of forming the shape of the support 63 by evaporating or melting a part of the substrate 62 May be.

The

UV irradiators

22A and 22B are disposed apart from each other in the front-rear direction, sandwiching the base material head 21 and effect component heads 26A to 26D described later. Specifically, the UV irradiation unit 22A is disposed on the front side of the substrate head 21, and the UV irradiation unit 22B is disposed on the rear side of the efficacy component head 26D.

Each of the drying

units

23A and 23B thermally dries the carrier forming solution, which is the liquid pulp discharged from the base material head 21 to the belt 46 of the transport unit 6. The drying

units

23A and 23B include, for example, heaters.

The drying

units

23A and 23B are disposed apart from each other in the front-rear direction with the base material head 21 and the effect component heads 26A to 26D interposed therebetween. Specifically, the drying unit 23A is disposed on the front side of the UV irradiation unit 22A, and the drying unit 23B is disposed on the rear side of the UV irradiation unit 22B. The positional relationship between the drying unit 23A and the UV irradiation unit 22A may be reversed. Further, the positional relationship between the drying unit 23B and the UV irradiation unit 22B may be reversed.

The effect component liquid applying unit 17 applies the effect component solution to the base material 62 and impregnates the same. The efficacy component liquid application unit 17 includes efficacy component heads 26A to 26D.

Each of the effect component heads 26A to 26D is a droplet discharge head which discharges the effect component liquid to the substrate 62 and applies it. The effect component heads 26A to 26D are arranged in parallel in the front-rear direction in the order of the effect component heads 26A to 26D from the front side on the rear side of the base material head 21. The effect component heads 26A to 26D each have two nozzle rows (not shown) similarly to the substrate head 21. The effect component heads 26A to 26D eject different types of effect component liquids from the respective nozzle rows. That is, the efficacy component liquid application unit 17 discharges eight types of efficacy component liquids in total by the efficacy component heads 26A to 26D. The effect component heads 26A to 26D, like the base material head 21, include multidrop inkjet heads.

The active ingredient liquid is a liquid in which an active ingredient having an effect on the skin of the face is contained in a liquid such as water or oil. In addition, the efficacy component liquid may contain optional additives such as preservatives, coloring agents, surfactants, and perfumes. Eight types of efficacy component liquids discharged from the efficacy component heads 26A to 26D are referred to as first to eighth efficacy component liquids.

The first efficacy component liquid contains a moisturizing component as an efficacy component. The moisturizing ingredient is used as an effective ingredient against skin soak. As the moisturizing component, hexanediol, alpha hydroxy acid, butylene glycol, dipropylene glycol, ceramide, hyaluronic acid, collagen or the like is used.

The second efficacy component liquid contains an anti-drying component as an efficacy component. The anti-drying component is used as an efficacy component against skin sores. As the drying preventing component, cetanol, cetyl ethylhexanoate, linoleic acid, polyquaterniums and the like are used.

The third efficacy component liquid contains a cell activation component as an efficacy component. The cell activation component is used as an efficacy component against freckles and stains. As the cell activation component, human oligopeptide, aspartic acid, marine purge, hydrolyzed conchiolin, niacinamide, etc. are used.

The fourth efficacy component liquid contains a whitening component as an efficacy component. The whitening component is used as an efficacy component against stains. As the whitening component, ascorbyl palmitate, nicotinamide, tranexamic acid, ascorbyl tetrahexyl decanoate, arbutin, placenta or the like is used.

The fifth efficacy component liquid contains a peeling component as an efficacy component. The peeling component is used as an efficacy component against freckles and stains. As the peeling component, alpha hydroxy acid, salicylic acid or the like is used.

The sixth efficacy component liquid contains an anti-wrinkle component as an efficacy component. The anti-wrinkle component is used as an efficacy component against wrinkles on the skin surface. As the anti-wrinkle component, ascorbyl tetrahexyldecanoate, astaxanthin, acetylhydroxyproline, acetyl hexapeptide and the like are used.

The seventh efficacy component liquid contains an ultraviolet light preventive component as an efficacy component. An ultraviolet protection component is used as an efficacy component against hidden stains. As the ultraviolet ray-inhibiting component, ethylhexyl toxylate arsenate, oxybenzo, t-butylmethoxydibenzoylmethane and the like are used.

The eighth efficacy component liquid contains an anti-inflammatory component as an efficacy component. The anti-inflammatory component is used as an efficacy component against redness and acne in the skin. As the anti-inflammatory component, tranexamic acid, stearyl glycyrrhetinate, nicotinamide and the like are used.

The first to eighth efficacy component liquids are adjusted in characteristics such as viscosity so that they can be discharged from the efficacy component heads 26A to 26D. Further, the type of ink jet head used as the effect component heads 26A to 26D may be selected according to the viscosity and the like of the first to eighth effect component liquids.

The print engine moving mechanism unit 4 moves the print engine unit 3 in the front-rear direction. The print engine moving mechanism unit 4 includes a guide unit 31 and a print engine moving motor 32.

The guide portion 31 is a member for guiding the print engine portion 3 to move in the front-rear direction. The print engine moving motor 32 moves the print engine unit 3 in the front-rear direction.

The supply unit 5 holds the support formation solution, the support formation solution, and the first to eighth efficacy component solutions, and supplies these to the print engine unit 3. As shown in FIG. 1 and FIG. 3, the supply unit 5 has the support forming liquid tank 36, the support forming liquid supply path 37, the support forming liquid tank 38, the support forming liquid supply path 39, and the effects. Component liquid tanks 40A to 40H and efficacy component liquid supply paths 41A to 41H are provided.

The support formation solution tank 36 stores the support formation solution. The support formation liquid supply path 37 is a path for feeding the support formation liquid from the support formation liquid tank 36 to the substrate head 21.

The carrier forming solution tank 38 stores the carrier forming solution. The holding body forming liquid supply path 39 is a path for feeding the holding body forming liquid from the holding body forming liquid tank 38 to the substrate head 21.

The efficacy component liquid tanks 40A to 40H respectively store first to eighth efficacy component liquids. The efficacy component liquid supply paths 41A to 41H are routes for feeding the first to eighth efficacy component liquids from the efficacy component liquid tanks 40A to 40H to the efficacy component heads 26A to 26D, respectively.

The transport unit 6 functions as a forming surface for forming the face pack 61 and transports the formed face pack 61 to the receiving unit 7. The transport unit 6 is disposed below the print engine unit 3.

The transport unit 6 includes a belt 46, a drive roller 47, driven rollers 48 to 50, and a belt drive motor 51.

The belt 46 constitutes a forming surface 46 a for forming the face pack 61 and conveys the formed face pack 61 to the receiving unit 7.

The belt 46 is an annular belt wound around the driving roller 47 and the driven rollers 48 to 50. The belt 46 is made of an elastic member such as rubber. The upper surface of the portion which becomes horizontal between the drive roller 47 and the driven roller 48 of the belt 46 is the forming surface 46 a of the face pack 61.

The drive roller 47 rotates the belt 46 in the clockwise direction in FIG.

The driven rollers 48 to 50 support the belt 46 together with the drive roller 47. The driven rollers 48 to 50 are driven to rotate by the belt 46. The driven roller 48 is disposed to the left of the drive roller 47 at the same height as the drive roller 47. The driven

rollers

49 and 50 are disposed at the same height apart from each other in the left-right direction at a position lower than the driving roller 47 and the driven roller 48.

The belt drive motor 51 rotationally drives the drive roller 47.

The receiving unit 7 receives the completed face pack 61 transported by the transport unit 6. The receiving unit 7 includes a receiving table 56 and a lift motor 57.

The receiving table 56 is a table for receiving the completed face pack 61. The receiving table 56 is disposed near the downstream side of the transport unit 6. The receiving stand 56 is configured to be able to move up and down.

The elevation motor 57 raises and lowers the receiving table 56.

The control unit 8 controls the overall operation of the face pack manufacturing apparatus 1. The control unit 8 is configured to include a processor, a memory and the like, specifically, a CPU, a RAM, a ROM, a hard disk and the like.

Next, a method of manufacturing the face pack 61 by the face pack manufacturing apparatus 1 will be described.

FIG. 5 is a flowchart of a method of manufacturing the face pack 61 by the face pack manufacturing apparatus 1.

First, in step S1 of FIG. 5, the control unit 8 executes a face measurement process. The face measurement step is a step of measuring the face of the user of the face pack 61 to acquire face information.

Specifically, the control unit 8 causes the three-dimensional imaging unit 11 to three-dimensionally image the face of the user. At this time, the control unit 8 causes the three-dimensional imaging unit 11 to execute color imaging and UV imaging. The three-dimensional imaging unit 11 generates three-dimensional imaging data by color imaging and three-dimensional imaging data by UV imaging, and outputs these to the control unit 8.

In addition, the control unit 8 causes the operator of the face pack manufacturing apparatus 1 to perform an operation of measuring the amount of water at each portion while making the skin moisture amount measuring portion 12 contact each portion on the user's face. The skin moisture amount measured by the skin moisture amount measuring unit 12 is acquired. Here, the skin moisture amount measured by the skin moisture amount measurement unit 12 is acquired as data of the skin moisture amount of each part on the face in the three-dimensional imaging data by the three-dimensional imaging unit 11. The data of the skin moisture content at each location on the face indicates the distribution of the area with the cover (face) on the face and the degree of the symptoms.

Next, in step S2, the control unit 8 executes an ejection data generation process. The discharge data generation step is a step of generating discharge data of the support formation liquid, the support formation liquid, and each of the efficacy component liquids. The ejection data is data indicating the number (drop number) of droplets ejected to each pixel in each of the base material head 21 and the effect component heads 26A to 26D.

Specifically, first, the control unit 8 generates face pack shape data based on three-dimensional imaging data by color imaging.

The face pack shape data is data including the two-dimensional shape of the face pack 61 and the uneven shape of the surface of the face pack 61 to be attached to the face. The face pack shape data two-dimensionally expands three-dimensional imaging data by color imaging to generate two-dimensional data of the face, and at the same time, data indicating the uneven shape of the skin surface in the three-dimensional imaging data by color imaging It is generated in combination with data. Here, the data indicating the uneven shape due to the wrinkles of the skin surface in the three-dimensional imaging data by color imaging indicates the distribution of the symptoms of the wrinkle and the degree thereof (the depth of the wrinkles).

The two-dimensional shape of the face pack 61 includes the outer shape of the base 62 in plan view, and the positions and shapes of notches 71A to 71E (see FIG. 9) described later. The cut portions 71A to 71E are formed to make the base 62 conform to the curved surface of the face.

The two-dimensional shape of the face pack 61 includes the positions and shapes of openings 72A to 72C (see FIG. 9) described later. The openings 72A to 72C are formed in a region avoiding the covering of the face pack 61 on the face. Specifically, the openings 72A to 72C are formed in regions corresponding to the eyes and the mouth.

Next, the control unit 8 analyzes three-dimensional imaging data by color imaging, and calculates a melanin value at each part of the face. The melanin level of each part of the face obtained by this color imaging indicates the distribution of freckles and stains on the face and the degree of their symptoms.

In addition, the control unit 8 analyzes three-dimensional imaging data by UV imaging, and calculates a melanin value in each part of the face. The melanin level of each part of the face obtained by this UV imaging indicates the distribution of hidden stains on the face and the degree of its symptoms.

Further, the control unit 8 analyzes three-dimensional imaging data by color imaging, and calculates a hemoglobin value at each part of the face. The hemoglobin value of each part of the face calculated from the three-dimensional imaging data by this color imaging indicates the distribution of redness and acne on the face and the degree of their symptoms.

Next, the control unit 8 maps the melanin value obtained by color imaging, the melanin value obtained by UV imaging, the hemoglobin value, and the skin moisture amount at each part of the face on the plane coordinates in the face pack shape data.

Next, the control unit 8 generates discharge data of the support formation liquid, the support formation liquid, and each of the efficacy component liquids based on the face pack shape data to which the melanin value and the like are mapped.

Specifically, the control unit 8 sets the number of drops for forming the support 63 made of a film of a predetermined thickness at each of the coordinates forming the two-dimensional shape of the face pack 61 as a support It is generated as discharge data of the forming liquid. In the discharge data of the support formation liquid, the drop number of each coordinate corresponding to the cut portion 71 and the opening 72 is set to 0.

In addition, the control unit 8 makes the support 63 thinner than the other portions, or forms the support 64, in order to cause the base 62 to bend along the face at a portion where the curvature of the jaw or the like is large. Ejection data of the support formation liquid is generated so as to provide a portion where 63 is omitted. Specifically, the controller 8 sets the drop number smaller than the drop number for forming the support 63 having a predetermined thickness as the drop number of the support forming solution in the portion where the support 63 is thinned. Do. Moreover, the control part 8 sets the drop number of support formation liquid to 0 in the part which abbreviate | omits the support 63 although the support 64 is formed.

Further, the control unit 8 generates data in which the number of drops for forming the holding body 64 is set at each coordinate forming the two-dimensional shape of the face pack 61 as ejection data of the holding body forming liquid.

Here, in the face pack 61, the thickness of the holding body 64 necessary for impregnating the efficacy component liquid is set according to the total number of drops of each efficacy component liquid (the total of the amounts of each efficacy component liquid). ing. As the total number of drops of the respective efficacy component liquids increases, the thickness of the necessary support 64 increases. Therefore, the control unit 8 sets the number of drops of the carrier forming liquid at each coordinate so that the thickness of the carrier 64 is adjusted according to the total number of drops of each of the efficacy component liquids.

In addition, the control unit 8 sets the number of drops at each coordinate so that the concavo-convex shape of the surface of the holding body 64 to be attached to the face has a shape corresponding to the concavo-convex shape due to wrinkles on the skin surface. For example, the control unit 8 sets the number of drops of each coordinate of the portion so that a convex portion corresponding to the depth is formed on the holding body 64 corresponding to the portion where the skin is dented by the wrinkles.

Further, also in the discharge data of the holding body forming liquid, the drop number of each coordinate corresponding to the cut portion 71 and the opening 72 is set to 0 as in the discharge data of the support forming liquid.

Moreover, in order that control part 8 may make base material 62 bend along a curved surface of a face, it forms support body 63, but it is provided with a part which omits support body 64. Generate Specifically, the control unit 8 sets the number of drops of the carrier forming solution to 0 at a portion where the carrier 63 is formed but the carrier 64 is omitted.

Further, the control unit 8 sets the number of drops of each of the efficacy component liquids based on the value of the melanin value or the like at each coordinate, and generates ejection data of each of the efficacy component liquids.

Specifically, the control unit 8 determines that the region where the melanin value obtained by color imaging is equal to or higher than the threshold is a region where there are symptoms of freckles and stains. Then, the control unit 8 sets the number of drops of at least one of the third to fifth efficacy component liquids for each coordinate of the region where the melanin value obtained by color imaging is equal to or greater than the threshold. The drop number is a value corresponding to the size of the melanin value obtained by color imaging at each coordinate.

Further, the control unit 8 determines that the region where the melanin value obtained by the UV imaging is equal to or more than the threshold is the region where the symptom of the hidden stain is present. And the control part 8 is the drop number of the 7th effect component liquid according to the magnitude | size of the melanin value obtained by UV imaging with respect to each coordinate of the area | region where the melanin value obtained by UV imaging is more than a threshold value Set

In addition, the control unit 8 determines that the region where the hemoglobin value is equal to or more than the threshold is a region where there are symptoms of redness and acne. Then, the control unit 8 sets the number of drops of the eighth efficacy component liquid according to the size of the hemoglobin value for each coordinate of the region where the hemoglobin value is equal to or greater than the threshold.

Further, the control unit 8 determines that the region in which the skin moisture amount is less than the threshold value is the region in which there is a symptom of a lump. Then, the control unit 8 sets the number of drops of at least one of the first and second efficacy component liquids for each coordinate of the region where the amount of skin moisture is less than the threshold. The number of drops is a value corresponding to the amount of skin water.

In addition, the control unit 8 sets the number of drops of the sixth efficacy component liquid according to the depth of the wrinkles at each coordinate of the area where the uneven shape due to the wrinkles is formed on the skin surface.

As described above, discharge data of the support formation liquid, the support formation liquid, and the discharge data of the respective efficacy component liquids as shown in FIG. 6 is generated. Here, each coordinate in the ejection data corresponds to a pixel at the time of printing by the base material head 21 and the effect component heads 26A to 26D.

By the way, when there are areas where a plurality of symptoms occur in duplicate on the face, in the discharge data of each effect component liquid, a plurality of types of effect component liquids are discharged to the same coordinates (the same area). The number of drops may be set. In this case, the control unit 8 sets the discharge order of a plurality of types of effect component liquid with respect to the same coordinates.

Specifically, the control unit 8 sets the discharge order so that the higher the priority of the efficacy component liquid is discharged later. The higher the degree of the corresponding symptom is, the higher the priority of the efficacy component liquid is. If the degree of symptoms is the same, the control unit 8 sets the discharge order based on the priority set in advance for each symptom or the priority specified by the user. The priority of the efficacy component liquid may be set from the viewpoint of the permeability of the efficacy component to the skin. When a plurality of types of efficacy component liquids are discharged for the same coordinates, the subsequently discharged effect component liquid is attached to the face of the holding body 64 in the thickness direction of the holding body 64 (base material 62) Placed near the side surface.

Next, in step S3 of FIG. 5, the control unit 8 executes a support formation process.

Specifically, the control unit 8 controls the print engine moving motor 32 to move the print engine unit 3 in the front-rear direction, and forms the conveyance unit 6 from the base material head 21 based on the discharge data of the support forming liquid. By discharging the support formation liquid onto the surface 46a, printing for one pass is performed. At this time, the control unit 8 cures the support forming solution by irradiating the support forming solution discharged onto the forming surface 46 a with ultraviolet light by the

UV irradiation unit

22A or 22B. Next, the control unit 8 controls the belt drive motor 51 to send the belt 46 rightward by the printing width of one pass.

The control unit 8 forms the support 63 as shown in FIG. 7 by alternately repeating the printing of one pass and the curing of the support forming solution and the feeding operation of the belt 46.

Here, when discharging the support formation liquid from the base material head 21 while moving the print engine unit 3 from the front side to the back side, the control part 8 controls the support formation liquid immediately after being discharged onto the formation surface 46a. The support forming solution is cured by irradiating ultraviolet rays from the UV irradiation unit 22A. Further, when discharging the support forming solution from the substrate head 21 while moving the print engine unit 3 from the rear side to the front side, the control unit 8 controls the support forming solution immediately after being discharged onto the forming surface 46a. The support forming solution is cured by irradiating ultraviolet light from the UV irradiation unit 22B.

Next, in step S4 of FIG. 5, the control unit 8 executes a holder formation step.

Specifically, first, the control unit 8 controls the belt drive motor 51 to send the belt 46 in the left direction, and returns the support 63 to a predetermined position.

Thereafter, the control unit 8 controls the print engine moving motor 32 to move the print engine unit 3 back and forth, and forms the holding body from the base material head 21 to the support 63 based on the discharge data of the holding body forming liquid. By discharging the liquid, printing for one pass is performed. At this time, the control unit 8 causes the

drying unit

23A or 23B to dry the support-forming solution discharged onto the support 63. Next, the control unit 8 controls the belt drive motor 51 to send the belt 46 rightward by the printing width of one pass.

The controller 8 alternately forms the holder 64 by laminating on the support 63 by alternately repeating the printing for one pass and the drying of the holder forming solution and the feeding operation of the belt 46. Thereby, the base material 62 which has the support body 63 and the holding body 64 is formed on the formation surface 46a. The holding body 64 is made of the pulp formed by drying the liquid pulp, and the effect component liquid penetrates into the interstices of the fibers to have a structure capable of impregnating the effect component liquid.

Next, in step S5, the control unit 8 executes an efficacy component liquid application process.

Specifically, first, the control unit 8 controls the belt drive motor 51 to send the belt 46 in the left direction to return the substrate 62 to a predetermined position.

Thereafter, the control unit 8 controls the print engine moving motor 32 to move the print engine unit 3 back and forth, and based on the discharge data of each of the effect component liquids, the corresponding one of the effect component heads 26A to 26D. Each effect component liquid is discharged from the effect component head 26 to the holder 64 of the base 62. The efficacy component liquid discharged to the holder 64 permeates into the holder 64 and is impregnated.

Here, when there is a region for discharging a plurality of types of effect component liquid to the same pixel (identical coordinates), the discharge order of each effect component liquid is set as described above. On the other hand, since the positional relationship in the front-back direction of the corresponding effect component head 26 of the effect component heads 26A to 26D for discharging the respective effect component liquids is fixed, the printing operation for one pass is performed only once. There are cases where the set discharge order can not be realized. Therefore, when there is a region for discharging a plurality of types of effect component liquid to the same pixel, the control unit 8 performs the printing operation by the movement of the print engine unit 3 from the front side to the back side and the movement from the back side to the front side. By combining with the printing operation, the discharge order of the set effect liquid components is realized.

When the discharge based on the discharge data of each of the efficacy component liquids in the area corresponding to the print width of one pass is completed, the control unit 8 controls the belt drive motor 51 to send the belt 46 rightward by the print width of one pass. .

As shown in FIG. 8, the control unit 8 alternately repeats the discharge of each of the effect component liquids to the area corresponding to the printing width of one pass and the feeding operation of the belt 46 to obtain each effect on the base material 62. Discharge the component liquid. When the discharge of the respective efficacy component liquids to the discharge target area of the entire base material 62 is completed, the manufacture of the face pack 61 is completed.

When the manufacture of the face pack 61 is completed, the control unit 8 controls the transport unit 6 to send the completed face pack 61 toward the receiving table 56. Then, the control unit 8 controls the receiving unit 7 to receive the face pack 61 from the transport unit 6 while lowering the receiving table 56.

Next, the face pack 61 manufactured by the face pack manufacturing apparatus 1 described above will be described.

FIG. 9 is a plan view of the face pack 61. FIG. FIG. 10 is a partial cross-sectional view of the face pack 61. As shown in FIG.

As shown in FIGS. 9 and 10, the face pack 61 includes a sheet-like base 62. The substrate 62 has a support 63 and a support 64.

The support 63 supports the holder 64. The support 63 is formed of a sheet-like liquid impermeable film.

The holder 64 holds the efficacy component liquid according to the user's face information. As described above, the holding body 64 is made of the pulp formed by drying the liquid pulp, and the effect component liquid penetrates into the interstices of the fibers to have a structure capable of impregnating the liquid. The holding body 64 is formed by being laminated on the support 63.

The external shape of the base 62 of the face pack 61 in plan view is formed in a shape obtained by two-dimensionally developing three-dimensional imaging data of the user's face. Further, as shown in FIG. 9, in the base 62 of the face pack 61, notches 71A to 71E and openings 72A to 72C are formed.

The incisions 71A to 71D are incisions for bringing the face pack 61 (base 62) along the contour of the face. The cut portion 71E is a cut for causing the face pack 61 (base material 62) to run along the nose. The cut portions 71A to 71E are formed by determining the arrangement and the shape based on the face shape information (three-dimensional imaging data) of the user.

The openings 72A to 72C are for avoiding coating of the face pack 61 (base material 62) with respect to the left eye, the right eye, and the mouth, respectively. The openings 72A to 72C are formed by determining the arrangement and the shape based on face shape information (three-dimensional imaging data) of the user.

Further, the holder 64 of the base 62 of the face pack 61 is impregnated with an efficacy component liquid of a type according to the face information.

For example, in the areas 73A to 73L shown in FIG. 9, the efficacy component liquid according to the symptom in the area on the user's face corresponding to each is impregnated. Here, the area 73A, the areas 73B to 73E, the

areas

73F and 73G, the areas 73H to 73J, and the

areas

73K and 73L are areas corresponding to different symptoms. However, in at least a part of the area on the face corresponding to each area 73, a plurality of symptoms may be overlapped. For this reason, in each area | region 73, at least one part of the said area | region 73 may be an area | region where multiple types of efficacy component liquids were impregnated in the same area | region.

As described above, since the regions 73A to 73L include a plurality of regions impregnated with the efficacy component liquid according to the different symptoms, the base 62 is impregnated with the efficacy component liquids of different types. There are multiple areas. For example, as shown in FIG. 10, the holder 64 has a region impregnated with the efficacy component liquid 76A and a region impregnated with the efficacy component liquid 76B different from the efficacy component liquid 76A. Here, each of the

efficacy component solutions

76A and 76B is any of the first to eighth efficacy component solutions.

Further, as described above, when there is a region in which a plurality of symptoms are generated in an overlapping manner on the face, the holding body 64 has a region in which a plurality of types of efficacy component liquids are impregnated in the same region in plan view. There is. For example, as shown in FIG. 11, the holding body 64 may have regions impregnated with different types of

efficacy component liquids

76C and 76D in the same region. In the example of FIG. 11, among the

efficacy component liquids

76C and 76D, the one with the efficacy component liquid 76C disposed near the surface of the support 64 to be attached to the face has a higher priority in this area. is there. Here, each of the

efficacy component liquids

76C and 76D is any of the first to eighth efficacy component liquids.

Note that all of the regions 73 in the holding body 64 into which the efficacy component liquid is impregnated may be impregnated with a plurality of types of efficacy component liquids in the entire region 73.

Further, the amount of each of the efficacy component liquids impregnated in the holder 64 of the face pack 61 is adjusted in accordance with the degree of the corresponding symptom.

Further, in the face pack 61, the thickness of the support 64 in each region for impregnating the efficacy component liquid is the amount of the efficacy component liquid to be impregnated (the total of the amounts of these components when impregnating multiple types of efficacy component liquids). Accordingly, the thickness is adjusted to the required thickness or more for impregnating the effect component liquid.

Further, in the face pack 61, the surface on the side to be attached to the face of the holding body 64 is formed with a concavo-convex shape according to the concavo-convex shape due to the wrinkles of the skin surface of the user. For example, as shown in FIG. 12, in the holding body 64, a convex portion 64a corresponding to the concave portion due to the wrinkles on the skin surface of the user is formed. In FIG. 12, the support component 64 is impregnated with the efficacy component liquid 76 which is any one of the first to eighth efficacy component liquids. The same applies to FIGS. 13 to 15 described later.

Further, the face pack 61 is provided with a support reducing portion 63a as shown in FIG. 13 which is formed to bend the base 62 along the face at a portion where the curvature of the face is large. The support reduction portion 63a is a portion where the support 63 is thinner than the other portions.

Further, in the face pack 61, a support-omitted portion 63b as shown in FIG. 14 formed to bend the base 62 along the face at a portion where the curvature of the face is large, and shown in FIG. Such a holder omission part 64b is provided. The support omission portion 63 b is a portion where the support 64 is present but the support 63 is omitted. The holder omission portion 64 b is a portion where the support 63 is present but the holder 64 is omitted.

The support reduced portion 63a, the support omitted portion 63b, and the holder omitted portion 64b are formed at appropriate positions according to the three-dimensional shape of the user's face.

The face pack 61 configured as described above is attached to the user's face such that the holder 64 contacts the user's face. As a result, the respective efficacy component liquids impregnated in the holder 64 contact the skin of the user's face and exert their effects.

As described above, in the face pack manufacturing apparatus 1 of the present embodiment, the efficacy component liquid application unit 17 imparts to the holding body 64 of the substrate 62 the efficacy component liquid according to the user's face information and impregnates it. . As a result, the face pack 61 can be provided that holds the efficacy component liquid according to the skin condition on the user's face, so that the user's effectiveness on the face can be enhanced.

Specifically, in the face pack manufacturing apparatus 1, the base 62 is impregnated with the efficacy component liquid of the type according to the symptom of each area for each area according to the symptom of the face. As a result, since it is possible to supply an efficacy component liquid suitable for the symptoms for each area of the face, the efficacy for the user's face can be enhanced.

Further, in the face pack manufacturing apparatus 1, the amount of the effect component liquid is adjusted according to the degree of the symptom of the face, so that the effect on the user's face can be further enhanced.

Further, in the face pack manufacturing apparatus 1, when impregnating the same region with a plurality of types of efficacy component liquids, the higher the priority of the efficacy component liquid, the closer to the surface of the base 62 to be attached to the face. As described above, the support component 64 of the base 62 is impregnated with the respective efficacy component liquids. Specifically, in the face pack manufacturing apparatus 1, when a plurality of types of efficacy component liquids are impregnated in the same region, the higher the priority of the efficacy component liquid is discharged to the holding body 64 later. Thereby, in the area | region where multiple types of effect component liquid was impregnated in the same area | region, according to a priority, the effect of each effect component liquid can be exhibited efficiently.

Further, in the face pack manufacturing apparatus 1, the thickness of the holding body 64 in each region is adjusted in accordance with the amount of the efficacy component liquid in each region in which the efficacy component liquid is impregnated. Thereby, the holding state of the efficacy component liquid in the face pack 61 can be maintained favorably.

Further, in the face pack manufacturing apparatus 1, the base material forming unit 16 forms the base material 62. For this reason, the face pack 61 can be manufactured without preparing the base material 62 separately.

Further, in the face pack manufacturing apparatus 1, the cut-out portion 71 and the opening portion 72 are formed based on the face shape information of the user. As a result, in accordance with the curvature of the user's face and the positions of eyes, nose, etc., the cut portions 71 and the openings 72 can be formed in appropriate shapes at appropriate positions. As a result, the face pack 61 can be made to correspond to the actual face shape of the user with high accuracy.

Further, in the face pack manufacturing apparatus 1, the uneven shape corresponding to the uneven shape of the skin surface of the user is formed on the surface of the holding body 64 on the side to be attached to the face based on the face shape information of the user. As a result, the effect component liquid can be brought into contact with the wrinkles of the user's face, so that the effect on the user's face can be further enhanced.

Further, in the face pack manufacturing apparatus 1, the sheet-like support 63 is formed, and the support 64 is stacked on the support 63 to form the base 62. Thereby, since the support 63 supports the holding body 64, it is possible to suppress the deformation of the face pack 61.

Further, in the face pack manufacturing apparatus 1, since the support 63 is formed of a liquid impermeable film, evaporation and outflow of the effect component liquid held by the holding body 64 can be suppressed, and the holding body 64 has a long effect component liquid It can hold.

Further, in the face pack manufacturing apparatus 1, a portion (support reduction portion 63a) in which the support 63 is thinner than the other portions is formed so that the base 62 is bent along the face. Thereby, the face pack 61 can be more closely attached to the face.

Further, in the face pack manufacturing apparatus 1, portions of the base material 62 where the support 63 or the holding body 64 is omitted (supporting body omitted portions 63 b, holding body omitted portions 64 b) so that the base material 62 bends along the face It is formed. Thereby, the face pack 61 can be more closely attached to the face.

Further, in the face pack manufacturing apparatus 1, the substrate forming liquid and the carrier forming solution are discharged by the base material head 21 which is an ink jet head (droplet discharge head) to form the base material 62. Thereby, the base 62 can be easily formed. In addition, the cut portion 71 and the opening 72 can be formed in the base 62 without performing the cutting process. Furthermore, it is possible to easily form a portion in which the support 63 is thinned (support reduction portion 63a) and a portion in which the support 63 or the support 64 is omitted (support omitted portion 63b and support omitted) 64b.

Further, in the face pack manufacturing apparatus 1, the effect component liquid is discharged by each of the effect component heads 26A to 26D which are ink jet heads (droplet discharge heads) to impregnate the substrate 62. Thereby, the effect component liquid can be easily applied to the substrate 62. Moreover, the application amount and application position of the effect component liquid to the base 62 can be finely adjusted.

[Other Embodiments]
Although the embodiments have been described as above, it should not be understood that the statements and drawings that form a part of this disclosure limit the present invention. Various alternative embodiments, examples and operation techniques will be apparent to those skilled in the art from this disclosure.

In the embodiment described above, the base 62 is formed in the face pack manufacturing apparatus 1, and the effect component liquid is applied to the formed base 62 to manufacture the face pack 61. However, the face pack may be manufactured by impregnating the separately prepared base material with an efficacy component liquid according to the face information by the face pack manufacturing apparatus 1.

In the embodiment described above, the melamine value, the hemoglobin value, the skin moisture amount, and the uneven shape due to wrinkles on the skin surface are used as information indicating the symptom on the face included in the face information, but a part of these is omitted. You may employ | adopt the measured value etc. which respond | correspond to another symptom.

In the embodiment described above, the substrate 62 of the face pack 61 is impregnated with a plurality of types of efficacy component liquids, but depending on the condition of the user's face, one type of efficacy component liquid is impregnated into the substrate 62 There is.

In the embodiment described above, the face pack 61 is manufactured using the face information obtained by measuring the user's face by the measurement unit 2 of the face pack manufacturing apparatus 1. However, facial information may be obtained from an external device. Further, the operator of the facepack manufacturing apparatus 1 may input the face information by operating the operation input unit (not shown). Further, the control unit 8 may store the user's past face information and manufacture the face pack 61 using the face information.

In the embodiment described above, the substrate forming liquid and the carrier forming solution are discharged by the substrate head 21 which is an inkjet head to form the substrate 62. Further, the effect component liquid was discharged onto the base 62 by each of the effect component heads 26A to 26D which are ink jet heads. However, not limited to the ink jet head, for example, at least one of a support formation liquid, a support formation liquid, and an efficacy component liquid may be discharged by a dispenser. Moreover, as long as it is a means which can discharge or inject a liquid also except that, a spray, a syringe, a scissors may be used, and what used the pump and the motor may be used. In addition, for example, in the case where the viscosity of the liquid is high or the like, in order to separate the liquid from the ejection port or the ejection port, a contact type separation means may be provided.

In the embodiment described above, the substrate 21 is formed using an inkjet head, but it is possible to use means such as heat melting, light curing phenomenon, adhesive, laser irradiation, cutting plotter, etc. used for a 3D printer. A substrate may be formed.

Although the multi-drop type inkjet head is used in the embodiment described above, a binary type inkjet head may be used.

In the embodiment described above, the formation of the substrate and the application of the component liquid were performed by the multipass method (serial method), but the single pass method (line method) may be used.

In the above-described embodiment, UV imaging is performed to acquire biological information (facial information). However, imaging using infrared light, microwaves, two-photon excitation fluorescence, and invisible light may be performed.

In the embodiment described above, the support 63 is formed of a film made of a UV curable resin, but may be formed of another material. Further, in the embodiment described above, the liquid pulp is dried to form the holding body 64, but the holding body 64 may be formed of another material such as a porous material which can be impregnated with a liquid.

In the embodiment described above, the base 62 has the support 63 and the holder 64, but the whole base may be a holder capable of impregnating the liquid.

In the embodiment described above, a portion where the support 63 is thinned on the base material 62 (support reduced portion 63a), and a portion where the support 63 or the support 64 is omitted (support omitted portion 63b, support omitted) 64b). However, depending on the shape of the user's face, any of these may be omitted.

In the embodiment described above, after the formation of the support 63 is completed, the support 64 is formed to complete the base 62, and then the efficacy component liquid is applied to the base 62. However, the face pack 61 is manufactured by forming the support 63, forming the holding body 64, and applying the effect component liquid to the base 62 for each printing width of one pass by the print engine unit 3. It is also good.

The substrate 62 may be formed so that a part thereof overlaps with another part. For example, a part of the portion covering the nose in the base 62 may overlap with the peripheral portion.

In the embodiment described above, the support 63 and the support 64 are formed by the base material head 21 to form the base material 62 based on the user's face information, and the effect component liquid is formed by each of the effect component heads 26A to 26D. It discharged to the base material 62 and manufactured the face pack 61. However, the face pack may be manufactured using each of the base material head 21 and the effect component heads 26A to 26D without using the user's face information. In this case, for example, the substrate head 21 is used to form a substrate having a predetermined standard shape. Then, a face pack is manufactured by discharging at least one kind of efficacy component liquid designated in advance from at least one of the efficacy component heads 26A to 26D to the base material. Alternatively, a face pack may be manufactured by discharging at least one kind of efficacy component liquid specified in advance to at least one of the efficacy component heads 26A to 26D to the substrate prepared in advance. .

In this case, a plurality of types of efficacy component liquids designated in advance are discharged to the respectively designated regions so that a plurality of regions impregnated with different types of efficacy component liquids are formed on the substrate. The substrate may be impregnated. As a result, since it is possible to set different efficacy component liquids for each area of the face, it is possible to provide an efficacy component liquid that is supposed to be suitable for each area, and to improve the user's effectiveness for the face.

In the embodiment described above, the case where the face pack covers the entire face has been described, but a part of the face may be covered.

Although the embodiment described above describes the case where the efficacy component holding sheet is a face pack, the efficacy component holding sheet is not limited to a face pack. For example, the efficacy ingredient holding sheet may be a medical sheet attached to a patient.

The medical sheet is obtained by impregnating a sheet-like base similar to the base 62 in the embodiment described above with an efficacy component liquid containing an efficacy component for medical use.

As an efficacy component for medical use, for example, as an efficacy component for symptoms such as sprain and muscle pain, there are NSAIDs (non-steroidal anti-inflammatory analgesics) such as diclofenac sodium, indomethacin and the like. In addition, bronchodilators, anti-inflammatory and analgesic agents, etc. are included as an effective ingredient for symptoms such as cough and asthma. In addition, as an effective ingredient for symptoms such as urticaria, itching and dermatitis, there are anti-allergic agents such as steroids and antihistamines. In addition, there are antibacterial agents, antibiotics and the like as an effective component against the symptoms such as trauma, tinea (athlete), and the like. In addition, antiviral agents and the like are included as an effective component against herpes virus and the like.

The medical sheet manufacturing apparatus has the same configuration as the face pack manufacturing apparatus 1 of the above-described embodiment. However, the skin water content measurement unit 12 of the measurement unit 2 is replaced with a measurement device for measuring the condition of the patient. Further, as the effect component liquid discharged by each of the effect component heads 26A to 26D, one containing the above-mentioned medical effect component is used. The medical sheet is manufactured by the same process as the face pack 61 of the embodiment described above in such a manufacturing apparatus.

Here, while the application target area of the face pack 61 of the embodiment described above is the user's face, the application target area of the medical sheet is an area corresponding to the patient's condition. Depending on the three-dimensional shape of the application target area of the medical sheet, at least one of the cut portion and the opening portion of the base may be unnecessary. For this reason, at least one of the cut portion and the opening portion of the substrate may be omitted. Similarly, at least one of a portion in which the support is thinned (support reduction portion) and a portion in which the support or the support is omitted (support portion omission portion, support portion omission portion) may be omitted.

In addition, depending on the surface shape of the area to which the medical sheet is to be attached and the condition of the patient, the uneven shape on the surface of the base according to the uneven shape due to the wrinkles of the skin may be unnecessary. For this reason, it may be omitted to form uneven | corrugated shape in the surface of the side affixed to the patient of a base material.

Further, when manufacturing the medical sheet, the operator of the medical sheet manufacturing apparatus may input the patient's condition to the manufacturing apparatus based on the diagnosis of a doctor or the like. In this case, a measuring device for measuring a patient's condition may be omitted in the medical sheet manufacturing apparatus.

Although the face pack which is an efficacy ingredient holding sheet in the embodiment mentioned above is stuck to a person, even if an efficacy ingredient holding sheet is stuck to living bodies, such as animals and plants other than humans, Good. For example, the medical sheet described above may be for animals.

In addition, the effect ingredient holding sheet may be a plant sheet to be attached to a plant. The plant sheet is obtained by impregnating a sheet-like base similar to the base 62 in the embodiment described above with an efficacy component liquid containing an efficacy component for plants.

As one of the effective ingredients for plants, there are benzimidazole-based fungicides such as thiophanate methyl. This effect component is for promoting healing of cut and wounds of plants. That is, this effect component prevents the invasion of pathogenic bacteria against the pruning of the plant, the cut end at the time of trimming, and the wound after scraping the diseased part, prevents withering, and accelerates the cure of the cut and the wound. is there.

The plant manufacturing apparatus has a configuration similar to that of the face pack manufacturing apparatus 1 according to the above-described embodiment. However, the skin water content measurement unit 12 of the measurement unit 2 is replaced with a measurement device for measuring a symptom of a plant. Further, as the effect component liquid discharged by each of the effect component heads 26A to 26D, one containing the above-mentioned effect component for plants is used. The plant sheet is manufactured by the same process as the face pack 61 of the embodiment described above in such a manufacturing apparatus.

Here, while the application target area of the face pack 61 of the above-described embodiment is the user's face, the application target area of the plant sheet is an area corresponding to a symptom of a plant. Depending on the three-dimensional shape of the application target area of the plant sheet, at least one of the cut portion and the opening portion of the base may be unnecessary. For this reason, at least one of the cut portion and the opening portion of the substrate may be omitted. Similarly, at least one of a portion in which the support is thinned (support reduction portion) and a portion in which the support or the support is omitted (support portion omission portion, support portion omission portion) may be omitted.

In addition, depending on the surface shape of the application target area of the plant sheet and the symptoms of the plant, the uneven shape of the substrate surface corresponding to the uneven shape of the plant surface may be unnecessary. For this reason, forming uneven | corrugated shape may be abbreviate | omitted in the surface of the side affixed to the plant of a base material.

Moreover, when manufacturing the sheet | seat for plants, the operator of the manufacturing apparatus of the sheet | seat for plants may be made to input the symptom of a plant to a manufacturing apparatus. In this case, in the plant manufacturing apparatus for plants, a measuring device for measuring the symptoms of plants may be omitted.

In addition, a powdered medicine containing the efficacy component may be applied to the base of the efficacy component holding sheet such as a face pack impregnated with the efficacy component liquid. In this case, the apparatus for producing an efficacy ingredient holding sheet is provided with a drug application unit for applying a powdered drug containing the efficacy component to a substrate, and the drug application unit is used as a substrate for the powdered drug on the substrate. It may be applied to This makes it possible to produce an efficacy ingredient holding sheet using a powdered drug. In addition, the powdered medicine applied to the substrate may contain a component that improves the fixability of the efficacy component liquid to the substrate.

Thus, it is a matter of course that the present invention includes various embodiments and the like which are not described herein. Accordingly, the technical scope of the present invention is defined only by the invention-specifying matters according to the scope of claims appropriate from the above description.

The present application discloses the following invention.

(Feature 1)
A method of producing an efficacy ingredient holding sheet to be attached to a living body, comprising:
A method for producing an efficacy ingredient holding sheet, comprising the step of impregnating a sheet-like base material with an efficacy ingredient liquid according to biological information.

(Feature 2)
The step of impregnating the effect component liquid is a step of discharging the effect component liquid onto the substrate by a droplet discharge head to impregnate the substrate with the effect component liquid. Method for producing an efficacy ingredient holding sheet.

(Feature 3)
The method for producing an efficacy component-holding sheet according to

feature

1 or 2, further comprising the step of forming the substrate.

(Feature 4)
In the step of forming the substrate,
A step of discharging a liquid, which is a material of a substrate, onto a forming surface of the above-mentioned efficacy component holding sheet by a droplet discharge head to form a substrate, and manufacturing the efficacy component holding sheet according to Feature 3 Method.

(Feature 5)
The biological information includes three-dimensional shape information of the surface of the living body to which the efficacy component holding sheet is attached,
In the step of forming the base material, based on the three-dimensional shape information, an incision component for making the base material along the surface of a living body is formed on the base material, the effect component according to

feature

3 or 4. Method of manufacturing holding sheet.

(Feature 6)
The biological information includes three-dimensional shape information of the surface of the living body to which the efficacy component holding sheet is attached,
In the step of forming the base material, an opening is formed in a region for avoiding coating of the base material on a living body based on the three-dimensional shape information. Efficacy according to any one of features 3 to 5 Method for producing a component holding sheet.

(Feature 7)
The biological information includes three-dimensional shape information of the surface of the living body to which the efficacy component holding sheet is attached,
In the step of forming the substrate, a concavo-convex shape corresponding to the concavo-convex shape of the surface of the living body is formed on the surface of the substrate to be attached to the living body based on the three-dimensional shape information. 3. The method for producing an efficacy ingredient holding sheet according to any one of 3 to 6.

(Feature 8)
The substrate has a support on which the effect component liquid is impregnated, and a support for supporting the support.
In the step of forming the substrate,
Forming the sheet-like support;
The process according to any one of Features 3 to 7, comprising the steps of: laminating on the support to form the support;

(Feature 9)
The method for producing an efficacy component-holding sheet according to Feature 8, wherein the step of forming the support is a step of forming the support by a liquid impermeable film.

(Feature 10)
The biological information includes three-dimensional shape information of the surface of the living body to which the efficacy component holding sheet is attached,
In the step of forming the support, a portion in which the support is made thinner than other portions is provided based on the three-dimensional shape information so that the substrate bends along the surface of the living body. Feature 8 Or the manufacturing method of the effect component holding sheet as described in or 9.

(Feature 11)
The biological information includes three-dimensional shape information of the surface of the living body to which the efficacy component holding sheet is attached,
In the step of forming the substrate, the substrate is provided with a portion where the support or the holder is omitted so that the substrate is bent along the surface of the living body based on the three-dimensional shape information. The method for producing an efficacy ingredient holding sheet according to any one of Features 8 to 10.

(Feature 12)
The biological information includes information indicating the distribution of each symptom on the surface of the living body to which the efficacy component holding sheet is attached,
In the step of impregnating the effect component liquid, the base material is impregnated with the effect component liquid of a type according to the symptom for each region according to the symptom on the surface of the living body based on the biological information. 11. The method for producing an efficacy component-holding sheet according to any one of 11.

(Feature 13)
The biological information includes information indicating the degree of symptoms on the surface of the living body to which the efficacy component holding sheet is attached.
In the step of impregnating the effect component liquid, the amount of each effect component liquid is adjusted according to the degree of the symptom on the surface of the living body.

(Feature 14)
The biological information includes information indicating the distribution of each symptom on the surface of the body to which the efficacy component holding sheet is to be attached, and the degree of each symptom,
The whole of the base material comprises a support capable of impregnating the effect component liquid,
In the step of impregnating the effect component liquid, based on the biological information, the base material is impregnated with an effect component liquid of a type according to the symptom in an amount according to the degree of the symptom for each region according to the symptom on the living body surface. It is a process,
In the step of forming the substrate, the thickness of the substrate in each region is adjusted in accordance with the amount of the efficacy component liquid to be impregnated in each region, according to any one of the features 3 to 7. Method for producing an efficacy ingredient holding sheet.

(Feature 15)
The biological information includes information indicating the distribution of each symptom on the surface of the body to which the efficacy component holding sheet is to be attached, and the degree of each symptom,
In the step of impregnating the effect component liquid, based on the biological information, the base material is impregnated with an effect component liquid of a type according to the symptom in an amount according to the degree of the symptom for each region according to the symptom on the living body surface. It is a process,
In the step of forming the holder, the thickness of the holder in each region is adjusted in accordance with the amount of the efficacy component liquid to be impregnated in each region, according to any one of the features 8 to 11. Method for producing an efficacy ingredient holding sheet.

(Feature 16)
In the step of impregnating the efficacy component liquid, when impregnating a plurality of types of efficacy component liquids in the same region, the higher the priority of the efficacy component liquid is, the more it adheres to the living body of the base in the thickness direction of the base The method for producing an efficacy component-holding sheet according to any one of the features 12 to 15, characterized in that each efficacy component solution is impregnated into the substrate so as to be disposed near the surface on the target side.

(Feature 17)
A method of producing an efficacy ingredient holding sheet to be attached to a living body, comprising:
A method for producing an efficacy component holding sheet, comprising the step of impregnating a plurality of types of efficacy component liquids in different regions with respect to a sheet-like substrate.

(Feature 18)
The method for producing an efficacy component-holding sheet according to any one of Features 1 to 17, further comprising the step of applying a powdery drug containing the efficacy component to a substrate impregnated with the efficacy component liquid.

(Feature 19)
An apparatus for producing an efficacy ingredient holding sheet to be attached to a living body, comprising:
An apparatus for producing an efficacy component holding sheet, comprising: an efficacy component liquid application unit for applying and impregnating an efficacy component liquid according to biological information to a sheet-like base material.

(Feature 20)
The apparatus for producing an efficacy component-holding sheet according to Feature 19, wherein the efficacy component liquid application unit ejects the efficacy component liquid onto the base material by a droplet discharge head and applies it.

(Feature 21)
The apparatus for producing an efficacy component-holding sheet according to feature 19 or 20, further comprising a base material forming unit that forms the base material.

(Feature 22)
The substrate forming portion is characterized in that a liquid which is a material of the substrate is discharged onto a formation surface of the efficacy component holding sheet by a droplet discharge head to form a substrate. The manufacturing apparatus of the effect component holding | maintenance sheet of description.

(Feature 23)
The biological information includes three-dimensional shape information of the surface of the living body to which the efficacy component holding sheet is attached,
The substrate according to feature 21 or 22, wherein the base material forming portion forms a cut portion on the base material along the surface of the living body based on the three-dimensional shape information. Sheet manufacturing equipment.

(Feature 24)
The biological information includes three-dimensional shape information of the surface of the living body to which the efficacy component holding sheet is attached,
The said component formation part forms an opening part in the area | region which avoids the coating with respect to the biological body of the said base based on the said three-dimensional-shaped information, The efficacy component holding in any one of the features 21 thru | or 23 characterized by the above-mentioned Sheet manufacturing equipment.

(Feature 25)
The biological information includes three-dimensional shape information of the surface of the living body to which the efficacy component holding sheet is attached,
The substrate forming unit is characterized in that a concavo-convex shape corresponding to the concavo-convex shape of the surface of the living body is formed on the surface of the substrate to be attached to the living body based on the three-dimensional shape information. An apparatus for producing an efficacy ingredient holding sheet according to any of 24.

(Feature 26)
The substrate has a support on which the effect component liquid is impregnated, and a support for supporting the support.
The base material forming unit is
The effect component-holding device according to any one of the features 21 to 25, wherein the base material is formed by forming the sheet-like support and laminating on the support to form the support. Sheet manufacturing equipment.

(Feature 27)
The apparatus for producing an efficacy component-holding sheet according to the feature 26, wherein the base material forming unit forms the support by a liquid impermeable film.

(Feature 28)
The biological information includes three-dimensional shape information of the surface of the living body to which the efficacy component holding sheet is attached,
The substrate forming unit is characterized by providing a portion in which the support is thinner than other portions so that the substrate bends along the surface of the living body based on the three-dimensional shape information. The manufacturing apparatus of the effect ingredient holding sheet as described in.

(Feature 29)
The biological information includes three-dimensional shape information of the surface of the living body to which the efficacy component holding sheet is attached,
The base material forming unit is characterized in that the base material is provided with a portion in which the support or the support body is omitted so that the base material bends along the surface of the living body based on the three-dimensional shape information. An apparatus for producing an efficacy ingredient holding sheet according to any one of features 26 to 28.

(Feature 30)
The biological information includes information indicating the distribution of each symptom on the surface of the living body to which the efficacy component holding sheet is attached,
The above-mentioned effect component liquid applying section applies the effect component liquid of the type according to the symptom to the base material for each region according to the symptom on the surface of the living body based on the biological information. An apparatus for producing an efficacy ingredient holding sheet according to any one of the above.

(Feature 31)
The biological information includes information indicating the degree of symptoms on the surface of the living body to which the efficacy component holding sheet is attached,
The apparatus for producing an efficacy component-holding sheet according to Feature 30, wherein the efficacy component liquid application unit adjusts the amount of each efficacy component solution according to the degree of the symptom on the living body surface.

(Feature 32)
The biological information includes information indicating the distribution of each symptom on the surface of the body to which the efficacy component holding sheet is to be attached, and the degree of each symptom,
The whole of the base material is made of a support which can be impregnated with the effect component liquid,
The effect component liquid applying unit applies the effect component liquid of the type according to the symptom to the base material in an amount according to the degree of the symptom for each region according to the symptom on the living body surface based on the biological information. And
The effect according to any one of the features 21 to 25, wherein the base material forming unit adjusts the thickness of the base material in each area according to the amount of the efficacy component liquid applied to each area. Component manufacturing sheet manufacturing equipment.

(Feature 33)
The biological information includes information indicating the distribution of each symptom on the surface of the body to which the efficacy component holding sheet is to be attached, and the degree of each symptom,
The effect component liquid applying unit applies the effect component liquid of the type according to the symptom to the base material in an amount according to the degree of the symptom for each region according to the symptom on the living body surface based on the biological information. Yes,
The effect according to any one of the features 26 to 29, wherein the base material forming portion adjusts the thickness of the support in each area in accordance with the amount of the efficacy component liquid to be impregnated in each area. Component manufacturing sheet manufacturing equipment.

(Feature 34)
When the effect component liquid application unit impregnates a plurality of types of effect component liquids in the same region, the higher the priority of the effect component liquid, the side of the substrate that is attached to the living body in the thickness direction of the substrate 30. The apparatus for producing an efficacy component-holding sheet according to any one of the features 30 to 33, wherein each efficacy component solution is applied to the substrate so as to be disposed near the surface of the substrate.

(Feature 35)
An apparatus for producing an efficacy ingredient holding sheet to be attached to a living body, comprising:
An apparatus for producing an efficacy component holding sheet, comprising: an efficacy component liquid application unit for applying and impregnating a plurality of types of efficacy component liquids in different regions with respect to a sheet-like base material.

(Feature 36)
The method according to any one of the features 19 to 35, further comprising a drug application portion for applying a powdered drug containing the efficacy component to a substrate impregnated with the efficacy component liquid. apparatus.

(Feature 37)
An effect ingredient holding sheet to be stuck to a living body,
Equipped with a sheet-like substrate,
An efficacy component holding sheet comprising: an efficacy component liquid according to biological information impregnated in the base material.

(Feature 38)
The substrate is characterized by having a cut portion formed along the three-dimensional shape of the surface of the living body to which the efficacy component holding sheet is to be attached, for bringing the substrate along the surface of the living body. The effect ingredient holding sheet as described.

(Feature 39)
The efficacy component-holding sheet according to feature 37 or 38, wherein the base material has an opening formed in a region for avoiding coating of the substrate on the surface of the living body to which the efficacy component-holding sheet is attached. .

(Feature 40)
The uneven shape according to the uneven shape on the surface of the living body to which the efficacy component holding sheet is to be attached is formed on the surface of the base on the side to be attached to the living body, any one of the features 37 to 39 The effect ingredient holding sheet as described in.

(Feature 41)
The substrate is
A support body into which the effect component liquid is impregnated;
30. An efficacy component holding sheet according to any one of the features 37 to 40, comprising: a support for supporting the holding body.

(Feature 42)
The efficacy component-holding sheet according to feature 41, wherein the support is formed of a liquid impermeable film.

(Feature 43)
The component according to feature 41 or 42, wherein the base is provided with a portion thinner than the other portion so that the base bends along the surface of the living body. Sheet.

(Feature 44)
The substrate according to any one of the features 41 to 43, wherein the substrate is provided with a portion omitting the support or the support so that the substrate bends along the surface of a living body. Effect ingredient holding sheet.

(Feature 45)
In any one of the features 37 to 44, the efficacy component liquid of the type according to the symptom is impregnated in the base material for each region according to the symptom of the living body surface to which the efficacy component holding sheet is attached. The effect ingredient holding sheet as described.

(Feature 46)
The amount of each of the efficacy component liquid is adjusted in accordance with the degree of the symptom on the surface of the living body to which the efficacy component holding sheet is to be attached. The efficacy component holding sheet according to the feature 45.

(Feature 47)
The whole of the base material is made of a support which can be impregnated with the effect component liquid,
The effect component liquid of the type according to the symptom is impregnated in the substrate in an amount according to the degree of the symptom for each region according to the symptom of the living body surface to which the efficacy component holding sheet is attached.
The thickness of the said base material in each area | region is adjusted according to the quantity of the effect component liquid in each area | region, The effect component holding sheet in any one of the characteristics 37 thru | or 40 characterized by the above-mentioned.

(Feature 48)
The support component of the base material is impregnated with an effect component liquid of a type according to the condition for each region according to the condition on the surface of the living body to which the effect component holding sheet is attached;
The efficacy component holding sheet according to any one of the features 41 to 44, wherein the thickness of the support in each region is adjusted in accordance with the amount of the efficacy component liquid in each region.

(Feature 49)
In a region in which multiple types of efficacy component liquids are impregnated in the substrate, the higher the priority of the efficacy component liquid, the closer the surface of the substrate on the side to be attached to the living body in the thickness direction of the substrate The efficacy component-holding sheet according to any one of the features 45 to 48, which is disposed in

(Feature 50)
An effect ingredient holding sheet to be stuck to a living body,
Equipped with a sheet-like substrate,
A plurality of regions impregnated with different types of efficacy component liquids are provided on the base material.

(Feature 51)
The efficacy component holding sheet according to any one of the features 37 to 50, wherein a powdery drug containing the efficacy component is applied to a substrate impregnated with the efficacy component liquid.
(Feature 52)
A substrate, which is a substrate, and is formed according to the three-dimensional shape of the surface of a living body to which the efficacy component holding sheet is to be attached.

The entire contents of Japanese Patent Application No. 201-148310 (filing date: July 31, 2017) are incorporated herein by reference.

Claims

A method of producing an efficacy ingredient holding sheet to be attached to a living body, comprising:
A method for producing an efficacy ingredient holding sheet, comprising the step of impregnating a sheet-like base material with an efficacy ingredient liquid according to biological information.
The step of impregnating the effect component liquid is a step of discharging the effect component liquid onto the substrate by a droplet discharge head to impregnate the substrate with the effect component liquid. Of producing the component holding sheet of
The method according to claim 1 or 2, further comprising the step of forming the base material.
In the step of forming the substrate,
The effect component holding sheet according to claim 3, which is a step of discharging a liquid which is a material of the base material onto the forming surface of the effect component holding sheet by a droplet discharge head to form the base material. Production method.
The biological information includes three-dimensional shape information of the surface of the living body to which the efficacy component holding sheet is attached,
In the process of forming the said base material, the cut part for making the said base material along a biological body surface is formed in a base material based on the said three-dimensional-shaped information, The effect as described in any one of Claim 3 or 4 characterized by the above-mentioned. Method for producing a component holding sheet.
The biological information includes three-dimensional shape information of the surface of the living body to which the efficacy component holding sheet is attached,
In the process of forming the said base material, an opening part is formed in the area | region which avoids coating with respect to the biological body of the said base material based on the said three-dimensional-shaped information, The manufacturing method of the effect component holding sheet as described.
The biological information includes three-dimensional shape information of the surface of the living body to which the efficacy component holding sheet is attached,
In the step of forming the base material, a concavo-convex shape corresponding to the concavo-convex shape of the living body surface is formed on the surface of the base material attached to the living body based on the three-dimensional shape information. 7. A method for producing an efficacy ingredient holding sheet according to any one of Items 3 to 6.
The substrate has a support on which the effect component liquid is impregnated, and a support for supporting the support.
In the step of forming the substrate,
Forming the sheet-like support;
The process according to any one of claims 3 to 7, further comprising the step of: laminating on the support to form the support.
The method of producing an efficacy component-holding sheet according to claim 8, wherein the step of forming the support is a step of forming the support by a liquid impermeable film.
The biological information includes three-dimensional shape information of the surface of the living body to which the efficacy component holding sheet is attached,
In the step of forming the support, a portion in which the support is made thinner than the other portion is provided so that the substrate bends along the surface of the living body based on the three-dimensional shape information. The manufacturing method of the effective ingredient holding sheet as described in 8 or 9.
The biological information includes three-dimensional shape information of the surface of the living body to which the efficacy component holding sheet is attached,
In the step of forming the substrate, the substrate is provided with a portion where the support or the holder is omitted so that the substrate is bent along the surface of the living body based on the three-dimensional shape information. The manufacturing method of the efficacy component holding sheet according to any one of claims 8 to 10.
The biological information includes information indicating the distribution of each symptom on the surface of the living body to which the efficacy component holding sheet is attached,
In the step of impregnating the effect component liquid, the base material is impregnated with the effect component liquid of a type according to the condition for each region according to the condition on the surface of the living body based on the biological information. A method for producing an efficacy ingredient holding sheet according to any one of 1 to 11.
The biological information includes information indicating the degree of symptoms on the surface of the living body to which the efficacy component holding sheet is attached.
The method according to claim 12, wherein in the step of impregnating the efficacy component liquid, the amount of each efficacy component liquid is adjusted according to the degree of the symptom on the living body surface.
The biological information includes information indicating the distribution of each symptom on the surface of the body to which the efficacy component holding sheet is to be attached, and the degree of each symptom,
The whole of the base material comprises a support capable of impregnating the effect component liquid,
In the step of impregnating the effect component liquid, based on the biological information, the base material is impregnated with an effect component liquid of a type according to the symptom in an amount according to the degree of the symptom for each region according to the symptom on the living body surface. It is a process,
The method according to any one of claims 3 to 7, wherein in the step of forming the substrate, the thickness of the substrate in each region is adjusted in accordance with the amount of the efficacy component liquid to be impregnated in each region. The manufacturing method of the effective ingredient holding sheet as described in-.
The biological information includes information indicating the distribution of each symptom on the surface of the body to which the efficacy component holding sheet is to be attached, and the degree of each symptom,
In the step of impregnating the effect component liquid, based on the biological information, the base material is impregnated with an effect component liquid of a type according to the symptom in an amount according to the degree of the symptom for each region according to the symptom on the living body surface. It is a process,
12. The method according to any one of claims 8 to 11, wherein in the step of forming the holder, the thickness of the holder in each region is adjusted in accordance with the amount of the efficacy component liquid to be impregnated in each region. The manufacturing method of the effective ingredient holding sheet as described in-.
In the step of impregnating the efficacy component liquid, when impregnating a plurality of types of efficacy component liquids in the same region, the higher the priority of the efficacy component liquid is, the more it adheres to the living body of the substrate in the thickness direction of the substrate. The method for producing an efficacy component-holding sheet according to any one of claims 12 to 15, wherein the substrate is impregnated with each efficacy component liquid so as to be disposed near the surface on the side to be treated.
A method of producing an efficacy ingredient holding sheet to be attached to a living body, comprising:
A method for producing an efficacy component holding sheet, comprising the step of impregnating a plurality of types of efficacy component liquids in different regions with respect to a sheet-like substrate.
The efficacy component holding sheet according to any one of claims 1 to 17, further comprising the step of applying a powdery drug containing the efficacy component to the substrate impregnated with the efficacy component liquid. Production method.
An apparatus for producing an efficacy ingredient holding sheet to be attached to a living body, comprising:
An apparatus for producing an efficacy component holding sheet, comprising: an efficacy component liquid application unit for applying and impregnating an efficacy component liquid according to biological information to a sheet-like base material.
20. The apparatus for producing an efficacy component-holding sheet according to claim 19, wherein the efficacy component liquid applying unit ejects the efficacy component solution to the base material by a droplet discharge head and applies the solution.
The apparatus for producing an efficacy component-holding sheet according to claim 19 or 20, further comprising a substrate forming part that forms the substrate.
The substrate forming unit is characterized in that a liquid, which is a material of the substrate, is discharged onto a forming surface of the efficacy component holding sheet by a droplet discharge head to form a substrate. The manufacturing apparatus of the effect ingredient holding sheet as described in.
The biological information includes three-dimensional shape information of the surface of the living body to which the efficacy component holding sheet is attached,
23. The effect component according to claim 21 or 22, wherein the base material forming portion forms a cut portion for making the base material along the surface of the living body on the base material based on the three-dimensional shape information. Holding sheet manufacturing equipment.
The biological information includes three-dimensional shape information of the surface of the living body to which the efficacy component holding sheet is attached,
The said base material formation part forms an opening part in the area | region which avoids the coating | cover with respect to the biological body of the said base material based on the said three-dimensional-shape information, The opening part is characterized by the above-mentioned. Production device for the effect ingredient holding sheet.
The biological information includes three-dimensional shape information of the surface of the living body to which the efficacy component holding sheet is attached,
22. The substrate forming unit according to claim 21, wherein an uneven shape corresponding to the uneven shape on the surface of the living body is formed on the surface of the base attached to the living body based on the three-dimensional shape information. An apparatus for producing an efficacy ingredient holding sheet according to any one of to 24.
The substrate has a support on which the effect component liquid is impregnated, and a support for supporting the support.
The base material forming unit is
26. The substrate according to any one of claims 21 to 25, wherein the substrate is formed by forming the sheet-like support and laminating on the support to form the support. Production device for the effect ingredient holding sheet.
The said base-material formation part forms the said support body with a liquid impervious film, The manufacturing apparatus of the efficacy component holding sheet of Claim 26 characterized by the above-mentioned.
The biological information includes three-dimensional shape information of the surface of the living body to which the efficacy component holding sheet is attached,
27. The substrate forming unit according to claim 26, wherein a portion of the support thinner than the other portion is provided such that the substrate bends along the surface of the living body based on the three-dimensional shape information. 27. The manufacturing apparatus of the effect component holding sheet as described in 27.
The biological information includes three-dimensional shape information of the surface of the living body to which the efficacy component holding sheet is attached,
The base material forming unit is characterized in that the base material is provided with a portion in which the support or the support body is omitted so that the base material bends along the surface of the living body based on the three-dimensional shape information. An apparatus for producing an efficacy ingredient holding sheet according to any one of claims 26 to 28.
The biological information includes information indicating the distribution of each symptom on the surface of the living body to which the efficacy component holding sheet is attached,
The effect component liquid applying unit applies, to the base material, an effect component liquid of a type according to a symptom based on the biological information and for each region according to the condition on the surface of a living body. An apparatus for producing an efficacy ingredient holding sheet according to any one of 29.
The biological information includes information indicating the degree of symptoms on the surface of the living body to which the efficacy component holding sheet is attached,
31. The apparatus for producing an efficacy component-holding sheet according to claim 30, wherein the efficacy component liquid application unit adjusts the amount of each efficacy component solution according to the degree of the symptom on the living body surface.
The biological information includes information indicating the distribution of each symptom on the surface of the body to which the efficacy component holding sheet is to be attached, and the degree of each symptom,
The whole of the base material is made of a support which can be impregnated with the effect component liquid,
The effect component liquid applying unit applies the effect component liquid of the type according to the symptom to the base material in an amount according to the degree of the symptom for each region according to the symptom on the living body surface based on the biological information. And
26. The substrate forming unit according to any one of claims 21 to 25, wherein the thickness of the substrate in each region is adjusted in accordance with the amount of the efficacy component liquid applied to each region. The manufacturing apparatus of the effect component holding | maintenance sheet of description.
The biological information includes information indicating the distribution of each symptom on the surface of the body to which the efficacy component holding sheet is to be attached, and the degree of each symptom,
The effect component liquid applying unit applies the effect component liquid of the type according to the symptom to the base material in an amount according to the degree of the symptom for each region according to the symptom on the living body surface based on the biological information. Yes,
The said base material formation part adjusts the thickness of the said holding body in each area | region according to the quantity of the efficacy component liquid with which each area | region is impregnated, The any one of Claim 26 thru | or 29 characterized by the above-mentioned. The manufacturing apparatus of the effect component holding | maintenance sheet of description.
When the effect component liquid application unit impregnates a plurality of types of effect component liquids in the same region, the higher the priority of the effect component liquid, the side of the substrate that is attached to the living body in the thickness direction of the substrate The apparatus for producing an efficacy ingredient holding sheet according to any one of claims 30 to 33, wherein each efficacy ingredient liquid is applied to the substrate so as to be disposed near the surface of the substrate.
An apparatus for producing an efficacy ingredient holding sheet to be attached to a living body, comprising:
An apparatus for producing an efficacy component holding sheet, comprising: an efficacy component liquid application unit for applying and impregnating a plurality of types of efficacy component liquids in different regions with respect to a sheet-like base material.
The composition according to any one of claims 19 to 35, further comprising a drug application portion for applying a powdered drug containing the efficacy component to a substrate impregnated with the efficacy component liquid. Sheet manufacturing equipment.
An effect ingredient holding sheet to be stuck to a living body,
Equipped with a sheet-like substrate,
An efficacy component holding sheet comprising: an efficacy component liquid according to biological information impregnated in the base material.
The substrate is characterized by having a cut portion formed along the three-dimensional shape of the surface of the living body to which the efficacy component holding sheet is to be attached, for making the substrate follow the surface of the living body. The effect ingredient holding sheet as described in.
The efficacy component-holding device according to claim 37 or 38, wherein the substrate has an opening formed in a region on the living body surface to which the efficacy component-holding sheet is to be attached that avoids coating of the substrate. Sheet.
The uneven shape according to the uneven | corrugated shape of the biological body surface of the sticking object of the said effect component holding | maintenance sheet is formed in the surface of the side affixed to the biological body of the said base material, The effect ingredient holding sheet as described in 1 or 2.
The substrate is
A support body into which the effect component liquid is impregnated;
The effect component holding sheet according to any one of claims 37 to 40, comprising: a support for supporting the holding body.
42. The efficacy component-holding sheet according to claim 41, wherein the support is formed of a liquid impermeable film.
The efficacy component according to claim 41 or 42, wherein the base is provided with a portion thinner than the other portion so that the base bends along the surface of the living body. Holding sheet.
44. The substrate according to any one of claims 41 to 43, wherein the support or the support is omitted so that the substrate bends along the surface of the living body. The effect ingredient holding sheet as described in.
45. The substrate according to any one of claims 37 to 44, wherein the substrate is impregnated with the efficacy component liquid of the type according to the symptom for each region according to the symptom of the living body surface to which the efficacy component holding sheet is attached. An efficacy ingredient holding sheet according to item 1.
The efficacy component holding sheet according to claim 45, wherein the amount of each efficacy component liquid is adjusted in accordance with the degree of the symptom on the surface of the living body to which the efficacy component holding sheet is attached.
The whole of the base material is made of a support which can be impregnated with the effect component liquid,
The effect component liquid of the type according to the symptom is impregnated in the substrate in an amount according to the degree of the symptom for each region according to the symptom of the living body surface to which the efficacy component holding sheet is attached.
The thickness of the said base material in each area | region is adjusted according to the quantity of the effect component liquid in each area | region, The effect component holding sheet of any one of the Claims 37 thru | or 40 characterized by the above-mentioned.
The support component of the base material is impregnated with an effect component liquid of a type according to the condition for each region according to the condition on the surface of the living body to which the effect component holding sheet is attached;
The thickness of the said holding body in each area | region is adjusted according to the quantity of the effect component liquid in each area | region, The effect component holding sheet of any one of the Claims 41-44 characterized by the above-mentioned.
In a region in which multiple types of efficacy component liquids are impregnated in the substrate, the higher the priority of the efficacy component liquid, the closer the surface of the substrate on the side to be attached to the living body in the thickness direction of the substrate The efficacy component-holding sheet according to any one of claims 45 to 48, which is disposed in
An effect ingredient holding sheet to be stuck to a living body,
Equipped with a sheet-like substrate,
A plurality of regions impregnated with different types of efficacy component liquids are provided on the base material.
The efficacy component holding sheet according to any one of claims 37 to 50, wherein a powdery drug containing the efficacy component is applied to a substrate impregnated with the efficacy component liquid.
A substrate,
A substrate provided with a cut portion formed along the three-dimensional shape of the surface of the living body to which the efficacy component holding sheet is to be attached, for making the substrate follow the surface of the living body.